Clinical Trial

Effects of Emicizumab Treatment in Patients With Hemophilia A

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 24, 2025 (before its estimated November 10, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of our study is to investigate the effects of emicizumab treatment on the musculoskeletal system in children with hemophilia A.
Trial Details
NCT Number NCT07190118
Lead Sponsor Hasan Kalyoncu University
Conditions Hemophilia A, Musculoskeletal Assessment, Musculoskeletal Abnormalities
Enrollment 20 participants
Start Date 2025-09-30
Primary Completion 2025-11-10 (estimated)
Study Completion 2026-02-10 (estimated)
Updated on ClinicalTrials.gov 2025-09-24